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Abstract: The solvent evaporation technique was used in this study to evaluate probiotics microencapsulation in
AQOAT/ dichloromethane matrix and cell viability was also measured to assess its potentials in industrial food
formulation processes. Cumulative release experiments using water blue dye as a model molecule was also used
to evaluate the prebiotic applications. Well-defined spherical AQOAT microcapsules [50.0 ìm ± (24.14)] were formed
from 5% AQOAT solution. Cells of Bifidobacterium breve and Lactobacillus plantarum were successfully encapsulated
with this technique. However, a 7 log and a 5 log reduction were recorded for B. breve and L. plantarum respectively
after 60 min in buffer (P<0.05). Results of this study showed that 1% AQOAT solution lowered viability by 1 log and
cell exposure to 10 ml dichloromethane resulted in a 3 log reduction, thus confirming bactericidal properties of both
polymer and organic solvent. DCM was however shown to have more bactericidal effects on the cells (P<0.001).
Cumulative release trials using 0.2% water blue dye solution showed a 40% loss and encapsulation efficiency (EE)
of 73.8% (±14.76). It was recommended that viability counts using this technique be further evaluated using other
organic solvents (such as ethyl acetate and chloroform) or other synthetic polymers so as to increase its applicability
in the food industry.
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INTRODUCTION
The need to ensure healthy living through dietary
practices is fast becoming an interesting area of
investigation in the Food industry worldwide. These
include the use of probiotics and prebiotics. Probiotics
are live microorganisms which when ingested in
adequate quantities confer one or more demonstrated
health benefits for the host such as increasing immunity
levels (Reid, 2001; Gill et al., 2001). These bacteria cells
have been recommended in treating health disorders such
as lactose intolerance, food allergies, diarrhea and colon
cancer (Szajewska and Mukowicz, 2001; Kallomaki et al.,
2003; Lee et al., 2003; Korugol and Koturogolu, 2005;
Szajewska et al.,2006). Prebiotics are specifically
fermented by certain probiotic bacteria and this has been
shown to have therapeutic effects as well (Roberfroid,
2001; Moro et al.,2002; Ziegler et al., 2007).
The health-promoting properties of synbiotics
(probiotics and prebiotics) have become an interesting
and prospective area of research with immune effects
attributed to modulation of the gut microflora of the host
(Gismondo et al.,1999; Femia et al.,2002;Chakraborti,
2011; Liong, 2008). They have thus been used in some
food formulations (Desmond et al., 2005). However, the
ability of bacteria cells to survive and multiply in the
intestine of the host is essential to them having an effect
on the host. Microencapsulation is one of the techniques
used to increase survival rates of sensitive
microorganisms against a range of unfavorable external
conditions in the host (Gismondo et al.,1999; Anal and
Singh, 2007).
Microencapsulation involves packaging the probiotic
microorganisms in a micron-range, closed capsule and
enables the content therein to be released under specific
conditions. This approach has been shown to release
cells at sustained and continuous rates in therapeutic
products (Murua et al.,2008). The use of polymer
microcapsules as delivery systems has been reported
and reviewed in recent literature to have desirable
pharmaceutical applications (Paul et al., 2011; Prakash et
al., 2011; Baffoni et al., 2012; Shaik et al., 2012). How
flexible or rigid they are plays an important role their
structure-function relationship as well as their scope of
application in the food and biomedical industries
(Morrisa et al., 2008). Some of the synthetic polymers
(produced from suitable monomers) that can be used for
encapsulation include polyesters, poly (ortho esters),
polyanhydrides and polyphosphazenes (Park et al., 2005;
Della Porta et al., 2012). The solvent evaporation
technique is the most extensively used method of
microencapsulation involving the formation of a double-
layer emulsion by vigorous stirring to remove the organic
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solvent, leaving solid microspheres. It has good process
reproducibility preparations, requires less time and less
operation skills (Tiwari and Verma, 2011). In this study,
solvent evaporation technique will be used to
encapsulate probiotic bacteria within an AQOAT shell
which is insoluble at pH d” 6.8.
The use of microencapsulation techniques in various
food formulations has also been recognized. High
success levels have been achieved in encapsulating
various food ingredients like minerals, flavors and
ascorbic acid. However, the microencapsulation of
probiotics suggests that the technique needs further
optimization as studies have shown varying successes
over the years (Vidhyalakshmi et al.,2009). This
technology has also been successful with inclusion of
prebiotics in food products. Adding inulin through a
double-microencapsulation technique was shown to
increase the viability of Lactobacillus acidophilus in
yoghurt (Ann et al.,2007).
In spite of the success of this technique in the food
industry, some key challenges have been identified which
require more thorough in vitro and in vivo investigations.
These constraints range from further evaluation and
optimization of the encapsulation process to investigating
the stability and viability of the bacteria cells, whilst
gaining a clearer understanding of the mechanisms of
actions of the probiotics themselves. There is also the
need to carry out more detailed studies to confirm the
ability of microencapsulation techniques to deliver
probiotic bacteria to their desired target while evaluating
the controlled release aspects (Kaliasapathy, 2002;
Prakash et al.,2011). It must be noted here that the
tremendous successes reported confirm that probiotic
and prebiotic microencapsulation will assume an
important therapeutic role in the future.
Investigations by Della Porta et al. (2012) explored the
use of solvent evaporation technique in producing poly
lactic co-glycolic acid (PLGA) microcapsules with L.
acidophilus as a model bacterium and recorded less than
5% viable cell count. The authors also emphasized that
the technique had high applicability as it can be used to
encapsulate genetically modified bacteria or dead cells
to improve therapeutic efficiency. As pH-dependent
gelling agents, hydrophilic biodegradable polymers such
as hydroxypropyl methylcellulose (HPMC) or AQOAT
have been used in developing controlled release
formulations. With a molecular weight of 18000, this
polymer is most noted for its characteristic high swelling
ability which may be a property that can be explored
(Sahoo et al.,2011). However, its use in encapsulating
bacterial cells or prebiotics in the food industry is yet to
be investigated.
The objectives of this study, therefore, are to evaluate
the solvent evaporation technique as described by Della
Porta et al. (2012) using AQOAT/ dichloromethane as a
model polymer and organic solvent respectively to assess
its applicability to encapsulate probiotics and evaluate
how the solvent preparation affects cell survival. Water
blue dye solution (hydrophilic particle) will be included
in the procedure to measure the encapsulation efficiency,
level of loss on exposure to acidic solution and controlled
release trials under simulated gastrointestinal tract
conditions. This will be used to evaluate the potentials
of this technique in encapsulating small-size prebiotics
such as fructo-oligosaccharides (FOS) and galacto-
oligosaccharides (GOS).
MATERIALS AND METHODS
Materials : AQOAT (AS-HF grade) was purchased from
Shin Etsu Co. Ltd. UK and dichloromethane (DCM) was
obtained from Sigma Aldrich Co. Ltd, France. The model
bacteria strains used were L. plantarum (high resistance)
and Bifidobacterium breve (high sensitivity). Strains
were grown at 37 °C for 12 h and 22 h respectively in
hunger tubes of 10 ml tryptone peptone yeast (TPY) broth
in an incubation chamber. The media used for this study
were (Wilkins Chalgren agar for Bifidobacterium breve
and MRS agar for L. plantarum) and phosphate buffer
saline (PBS) solution at pH 7.2. Water blue dye (used as
the small molecule model), gastric solution (0.2% NaCl,
pH 2.0), The pH of solutions containing AQOAT
microcapsules in acid exposure trials were adjusted using
2 M HCl and 1 M NaOH solutions
Experimental
Formulation of suitable polymer concentration:
Preliminary tests were carried out to determine the
appropriate concentration of AQOAT for
microencapsulation. A known weight of AQOAT was
dissolved in 10 ml DCM for 24 h. The primary emulsion
was formed by adding 0.5 ml of distilled water the
dissolved polymer matrix in 10 ml DCM and stirring at
1200 rpm using an overhead stirrer. The secondary
emulsion was formed by adding the primary emulsion to
1% sodium alginate solution (surfactant) and stirred at
1200 rpm for 1 h. The solution was centrifuged at 3000
rpm for 5 min to separate microcapsules from solvent.
The supernatant was discarded and samples of
microcapsules were viewed under a light microscope
before and after freeze-drying for 22 h.
Probiotic experiment
Biomass production: Viable cells of L. plantarum were
obtained from a two-step process. Cells from a frozen
culture (stored at -80 °C) were streaked on Petri dishes
containing MRS agar and left for 48 h to grow. Isolated
colonies were inoculated into a 10 ml TPY broth under
anaerobic conditions and stored in an incubation chamber
for 12 h to obtain maximum exponential growth. The
starting optical density (OD) for this strain was 2.6. An
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aliquot was obtained from this tube and re-inoculated
into a new TPY broth in the second propagation for 12 h.
This was done using the formula:
C1V1=C2V2
where  C1 = measured OD from first hunger tube; V1=
volume of aliquot to be re-inoculated into the second
TPY tube (ìl); C2 = initial concentration of cells (0.1) which
corresponds to an OD of 2.0, and  V2 = volume of TPY in
a new hunger tube = 10 ml
An optical density of 2.6 after growth was used for each
experiment. Solution was centrifuged at 3200 rpm for 10
mins at 4 °C and supernatant was discarded to obtain
cells. For B. breve, isolated colonies were obtained 48 h
after streaking and the first cell propagation phase was
for 22 h in TPY to obtain maximum exponential growth.
The optical density was measured and adjusted to 0.1 by
re-inoculating an aliquot in a new10 ml TPY hunger tube.
This was incubated at 37 °C for 22 h in an incubation
chamber and the OD was checked afterwards. Cells were
prepared afterwards as described for L. plantarum.
Emulsion preparation: A w/o/w emulsion was formed
using solvent evaporation following the procedure of
Della Porta et al. (2012). A 5% AQOAT solution was
prepared in DCM and stirred for 24 h for complete
dissolution. A 0.5 ml vortexed cell solution was added to
the 5% AQOAT solution and stirred at 1200 rpm for 1 min
using an overhead stirrer to form the primary emulsion.
The primary emulsion was then added to a 1% sodium
alginate solution and stirred for 60 min using the overhead
stirrer to form the secondary emulsion. The final solution
was then centrifuged at 3000 rpm for 5 min at 4 °C and the
supernatant removed to obtain AQOAT microcapsules.
Cell viability counts: The starting cell concentration was
obtained by spreading 0.1 ml of cell suspension (for L.
plantarum or B. breve) on agar-filled Petri dishes at 107
and 108 dilution factors. Each experiment was carried out
in triplicate giving a total of 6 plates for the two dilution
factors. After microencapsulation of bacterial cells, the
AQOAT microcapsules were dissolved in 50 ml PBS
solution (pH - 7.2) to expose the cells. Various dilutions
were made in dilution bottles containing PBS solution
(10-2, 10-4, 10-6 and 10-7) to ensure easy counting of
isolate colonies. An aliquot of 0.1 ml L. plantarum cells
was spread on Petri dishes containing MRS agar at 0, 30
and 60 min after incubation of the cells in PBS buffer. An
equivalent volume of B. breve cells was spread on Wilkins
Chalgren agar-filled Petri dishes with the same dilution
factors for L. plantarum. Plates were stored in an
anaerobic cabinet for 2 d and isolate cell colonies were
counted afterwards.
Dye experiment: Water blue dye (obtained from Sigma
Aldrich, UK) was used as a model molecule for small
prebiotic compounds such as GOS and FOS to evaluate
recovery after acid exposure and controlled release trials.
A volume of 0.5 ml from freshly-prepared 0.2% dye
solution was added to a 5% AQOAT solution and stirred
at 1200 rpm for 2 min to form the primary emulsion.
Secondary emulsion was formed by adding the primary
emulsion to 1% sodium alginate solution and stirred for
60 min at 1200 rpm. Solution was centrifuged at 3000 rpm
for 5 min to obtain microcapsules. A volume of 50 ml
gastric solution (0.2% NaCl, pH 2.0) was used to re-
suspend AQOAT microcapsules and samples were taken
in 2 ml vials at 0 and 60 min after incubation in a water
bath at 37 °C. Volume of gastric solution was kept constant
throughout the procedure by replacing the aliquot
withdrawn for UV analysis with an equal amount of
gastric solution. Centrifugation was done at 3000 rpm for
5 min and the supernatant removed. Microcapsules were
re-suspended in 50 ml buffer solution and samples
collected at 15, 30, 45 and 60 min after dissolution. All
samples were analyzed by measuring absorbance using
a UV spectrophotometer at wavelength of 577 nm. PBS
solution was used as the blank for all trials. Standards
were run in gastric and buffer solutions to measure pH-
sensitivity of the dye.
Statistical analysis: The results are presented as means
± standard deviation. Cell viability with time was analyzed
by linear regression. The anti-microbial effect of AQOAT
and DCM on cell survival was compared by t-test.
Statistical analyses were done with Genstat (Genstat®
13th Edition, VSN Intl. Ltd, UK).
RESULTS
Different sizes of microcapsules were obtained, each
depending on the AQOAT concentration used for the
formulation (Fig 1). Images viewed under a light
microscope showed an increase in microcapsule size as
the concentration increased. All concentrations however
gave well-formed, spherical microcapsules. The scale bar
for each image was 75µm.
Table 1 shows results of preliminary tests carried out to
determine a suitable polymer concentration for this study.
The concentration ranged from 1%  to 10% . Quality of
microcapsule formed slightly decreased with increasing
polymer concentration. Microcapsules showed increased
gelation and the 10% solution in particular showed high
wastage of polymer.
Fig 2 shows viability counts (log cfu ml-1) for the two
strains of bacteria used in this study- L. plantarum and
B. breve cells before encapsulation, 30 min and 60 min
after incubation in buffer solution. Counts were
significantly different (pÂ0.05) after 30 min in buffer but
no significant difference was observed after 60 min when
all microcapsules had completely dissolved. Although
final cell count were low, L. plantarum cells was shown
to be more suitable for the procedure as a 5 log cell
reduction was recorded as against a 7 log reduction for
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B, breve strain.
The effects of 1% AQOAT solution and 10 ml DCM on B.
breve cells were also investigated.  The results show a 1
log cell reduction with 1% AQOAT solution after 60 min
while a 3 log reduction was recorded with DCM.
Significant differences in cell concentration were
observed after 60 min confirming that both organic solvent
and model polymer had killing effects on probiotic cells
with DCM having a higher impact.
In vitro results showed that 73.8% (±14.76) dye solution
(small molecule model) was successfully encapsulated
and released after 60 min of microcapsule dissolution in
buffer (Fig 4). Minimum encapsulation efficiency (EE)
value shows that 59.1% of the dye was retained by the
microcapsules during the 60 min incubation period in
gastric solution (0.2% NaCl, pH 2.0) and released over a
60 min period when microcapsules were dissolved in
buffer solution. This is equivalent to a maximum dye loss
of 40.9%.
DISCUSSION
Preliminary test results: microcapsule size and
morphology: Preliminary tests for microcapsule formation
were successful giving a mean size of 50.0 µm (±24.14)
with a 5% AQOAT solution. Light microscope images
showed spherical microcapsules with smooth outer
surfaces (Fig 1). This was observed to be consistent for
all the trial concentrations prepared in this study (1, 3, 5
and 10%). Sizes of microcapsules were observed to
increase with increasing AQOAT concentration. The
largest sizes were formed from a 10% AQOAT solution
(68.1 µm ±27.54) which is favorable for probiotic and
prebiotic microencapsulation. This was the highest
AQOAT concentration formed due to gelling problems.
High wastage of polymer and DCM was also observed
as AQOAT dissolution took a longer time and more DCM
was required for each trial. This could be due to the highly
viscous nature of AQOAT as it has been reported to
have a characteristic swelling ability (Sahoo et al.,2011).
Microcapsule sizes ranged from 21.3 µm ± 4.57 (1%
AQOAT solution) to 68.1 µm ± 27.54 (10% AQOAT
solution) thus indicating a positive correlation between
polymer concentration and microcapsule size (Table 1).
This means that as the AQOAT concentration was
increased, so did the sizes of the resultant microcapsules.
However, the resulting solutions become more viscous
and eventually gel at the 10% concentration. The size of
microcapsules to be used depends on its intended use
(Heidebach, et al.,2010) and the parameters for the
formulation in this study were low wastage, less gelling
and size of at least 50 µm for encapsulation of the bacterial
cells. There was a strong positive linear relationship (R2
= 0.95) between AQOAT concentration and microcapsule
size. The equation for the relationship is given as:
Microcapsule size = 18.7 (±2.98) + 5.2 (±0.54) *AQOAT
concentration
The 5% concentration was chosen for this study because
of large microcapsule size (50 µm) compared to lower
concentrations (3 and 1%), well-formed microcapsules
and minimal wastage compared to a 10% AQOAT
solution, (Table 1). Particle size and microcapsule
microstructure have been reported to vary with the
biopolymer used as wall material (Pedroza-Islas et
al.,1999)(a)
Probiotic experiments
Cell viability counts: Cell survival of L. plantarum and
B. breve decreased (P<0.001) linearly (R2=0.61) with time
(Figure 2). The equation of the relationship is given by:
Cell viability = 1.41exp10 (±9.83exp8) + (-2.83exp8±2.53exp7)
* time, with viability in cfu ml-1and time defined in min.
Although, t-test of the null hypothesis that mean cell
survival at 60 mins of B. breve was equal to that of L.
AQOAT 
concentration (%) 
Microcapsule size (μm)a Gelling 
properties 
Remarks  
1 21.3 ± 4.57 Low Well-formed microcapsules, 
minimal wastage of polymer but 
too small for bacteria 
encapsulation  
3 33.8 ± 8.11 Low Same as above  
5 50.0±24.14 Moderate Good size for bacteria 
encapsulation with well-defined 
microcapsules, minimal wastage 
and  
10 68.1±27.54 High Large-size, well-defined 
microcapsules for bacteria 
encapsulation but high wastage  
Table 1. Relationship between AQOAT concentration and microcapsule size.
aMeans are of three replicates each of five runs (± standard deviation)
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plantarum was accepted (P=0.359), cell survival of B.
breve was lower (P<0.001) at 30 min compared to L.
plantarum at the same time (Fig 2).
Cells of both strains were successfully encapsulated
using solvent evaporation technique. Average plate
counts for B. breve before encapsulation and after
encapsulation (30 and 60 min in buffer) were 1.01 X 1010,
4.06 X 103 and 2.14 X 103 cfu ml-1 respectively. This implies
a 7 log reduction or 0.00001% cell survival. B. breve is a
more sensitive gram positive bacteria strain than l.
plantarum and this may have been responsible for lower
cell viability counts. Further investigations are however
required to confirm this as studies on strain-specificity
levels may increase its applicability for future uses in the
food industry. Average cell concentration before and after
encapsulation (30 min and 60 min in buffer) were 1.02 X
1010 cfu ml-1, 6.78 X 107 cfu ml-1 and 3.12 X 105 cfu ml-1
respectively. This implies a 3 log cell and 5 log cell
reductions after 30 min and 60 min respectively in buffer.
These findings compare favorably with recent studies
that the concentration of probiotic bacteria in food
products should be at least 106 to 107cfu g-1 prior to
consumption (Nualkaekul et al.,2012). Solvent
evaporation technique may thus be recommended as
suitable for encapsulating probiotic bacteria such as L.
plantarum for use in fermented food products as well as
other formulations. The viability counts of L. plantarum
and B. breve can also be increased by optimizing the
solvent evaporation technique. Optimization might be
carried out by replacing the organic solvent used in this
study with others, such as chloroform or ethyl acetate,
adjusting the stirring speed to control shearing rate
during encapsulation or re-suspending bacteria cells with
other agents other than the supernatant after
centrifugation and before encapsulation.
The results of this study agree with the findings of Della
Fig. 1. Images of microcapsule morphologies from different AQOAT concentrations (a) 1% (b) 3% (c) 5% and (d) 10%.
(A) (B)
(C) (D)
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Porta et al. (2012) that cell viability was Â 5% but in
addition gives more specific details regarding viable cell
counts and possible factors that may have lowered it.
However, Della Porta et al. (2012) stated that the PLGA
microcapsules were dissolved in an MRS broth for 36 h
to release the cells for viability counts. This may have
contributed to low viability as a previous study showed
that PLGA microcapsule dissolution takes a longer time
to occur (Graves et al.,2004). It was also observed in
Della Porta’s publication that the conclusion of less than
5% viability was not specific as this may mean bacteria
cell counts from anywhere between 102 to 108 cfu g-1. The
current study gives specific detail in this regard to further
corroborate the conclusion of Â 5% viability by Della
Porta et al. (2012); 7- and 5-log cell reduction in B. breve
and L. plantarum respectively after 60 min of
microcapsule dissolution in buffer.
Test for cell killing effects of AQOAT and DCM: Average
viability counts for B. breve cells at the start of experiment
and after 60 min in 1% AQOAT solution were 1.36 X 1010
cfu ml-1 and 6.19 X 109 cfu ml-1 respectively, resulting in a
1 log reduction (Fig 3). This suggests that AQOAT has
some killing effects on cells as well as other poor enteric
properties. Comparisons using t-test however showed
Fig. 3. Bactericidal effects of AQOAT and DCM on B. breve cells.
Note: NS (not significant) or *** (= P<0.001) represent significance level at same times.
Fig. 2. Viability counts  for L. plantarum and B. breve cells
Note: NS (not significant) or * (= P<0.05) represent significance level at same times.
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no significant effects of AQOAT and DCM on initial cell
concentration. Results also showed significant effects
of DCM on viability of B. breve cells after 60 min. Average
cell counts before and after microencapsulation were 1.44
X 1010 and 1.33 X 107 cfu ml-1 respectively, indicating a 3-
log reduction (0.1% cell survival). Comparison by t-test
showed greater effects (PÂ0.0001) of DCM on viability
than AQOAT. This finding suggests that the nature of
polymer and organic solvent used are important
parameters in evaluating the applicability of solvent
evaporation technique in cell microencapsulation and
viability. Other solvents which are volatile and immiscible
with water (e.g ethyl acetate and chloroform) can be used
in future studies to evaluate cell recovery using this
technique.
The results of this study agree with the findings of Della
Porta et al. (2012) that cell viability was Â 5% but in
addition gives more specific details regarding viable cell
counts and possible factors that may have lowered it.
However, they stated that the PLGA microcapsules were
dissolved in an MRS broth for 36 h to release the cells for
viability counts. This may have contributed to low
viability as a previous study showed that PLGA
microcapsule dissolution takes a longer time to occur
(Graves et al.,2004). It was also observed in Della Porta’s
publication that the conclusion of less than 5% viability
was not specific as this may mean bacteria cell counts
from anywhere between 102 to 108 cfu g-1. The current
study gives specific detail in this regard to further
corroborate the conclusion of Â 5% viability by Della
Porta et al. (2012); 7- and 5-log cell reduction in B. breve
and L. plantarum respectively after 60 min of
microcapsule dissolution in buffer.
Cumulative release experiment using water blue dye:
The successful encapsulation of this small model
molecule and its release rate into the small intestine
strongly suggests the potential protective effects of this
technique on prebiotics such as fructo-oligosaccharides
(FOS) and galacto-oligosaccharides (GOS). The loss of
color intensity of water blue dye in buffer with increasing
time is suggestive of pH-sensitivity. The dye appears
most stable and retains its color at lower pH values as
lower absorbance readings were observed from dye
solution in buffer compared to dye molecules in gastric
solution (pH 2.0).
Results from dye encapsulation experiments showed
minimal dye loss in 1% alginate solution. This may be
due to interactions between the hydrophobic ends of
the dye and alginate solution during emulsification and
centrifugation. The use of hydrophobic fluorescent dyes
coated in thin PLGA films in formulating hydrophobic
drug compounds has been reported (Steele et al.,2011).
The authors showed that all fluorescent dyes
successfully encapsulated in PLGA and released at
desirable rates. Alginate has been successfully used in
the food and beverage industry as a gelling agent and a
colloid stabilizer (Brunetti, 2006). Cell viability evaluation
results from the probiotic bacteria models used in this
study also confirm that alginate had no killing effects on
cells thus suggesting its use as an ideal surfactant in
various food formulations. Its use as s surfactant in future
studies involving bacteria cell and prebiotic
encapsulation is thus recommended.
The use of PLGA microcapsules in Della Porta et al. (2012)
was not tested for controlled release trials using prebiotic
models. This may be so because PLGA polymer is non-
pH and non-temperature responsive and is thus likely to
have longer release times in the gastrointestinal tract of
Fig. 4. Acid exposure and controlled-release profile of encapsulated water blue dye
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the host (Graves et al.,2004). The need to evaluate the
hydrophobicity of the polymer has also been
recommended to improve its short-term and long-term
release potentials (Makadia and Siegel, 2011). In this
study, data from dye experiments strongly suggests that
the solvent evaporation technique may be used to
successfully encapsulate and release prebiotic materials
at desired controlled rates into the small intestine where
they are selectively fermented for the proliferation of
beneficial gram positive bacteria strains.
Results from this study have shown that the use of
probiotics and prebiotics prepared using solvent
evaporation technique have the potentials to create a
variety of products in the food industry that can be used
for therapeutic purposes, thus confirming recent reports
(Baffoni et al.,2012; Prakash et al.,2011; Shaik et al.,2012).
The synergistic effects of both probiotics and prebiotics
have the propensity to deliver delicate food ingredients
to target cells in both humans and animals. These strains
of bacteria can be used in the formulation of diverse
functional foods appealing to different age groups of
the population. Further studies are therefore required to
optimize microcapsule size, choice of organic solvent and
shearing rate among other parameters to increase the
applicability of this symbiotic combination.
Conclusion
Microencapsulation is an important tool by which
probiotics and prebiotics are protected and conveyed to
target sites. This study showed that bacteria cells were
successfully encapsulated using solvent evaporation
technique but low viability was observed after 60 min in
buffer. Viability counts were more specific on how low
the counts were. Both AQOAT and DCM were shown to
lower cell viability with increasing time, DCM having a
more significant effect. Higher cell viability of L.
plantarum over B. breve suggests that it may be a strain-
specific procedure and can be optimized by using a
suitable organic solvent (such as chloroform or ethyl
acetate). The use of alginate as a surfactant was shown
to have no significant side effects on cell viability and
dye recovery trials. Results from dye encapsulation
experiments showed that 60% of dye can be successfully
encapsulated with a 40% loss after 60 min in gastric
solution. It is however recommended that the technique
be further optimized to enhance cell viability and also
that further studies on polymer loading, acid degradation
and controlled release be carried out to evaluate the
protective potentials of this technique on prebiotics such
as fructo-oligosaccharides (FOS), galacto-
oligosaccharides (GOS) and inulin.
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